狼疮肾炎诊疗规范

2021-09-05 中华医学会风湿病学分会 中华内科杂志

狼疮肾炎是系统性红斑狼疮引起的肾损害,主要表现为血尿、蛋白尿、水肿、高血压和肾功能不全等。现有的诱导治疗方案对增殖性狼疮肾炎的完全缓解率偏低,且狼疮肾炎容易复发。

中文标题:

狼疮肾炎诊疗规范

发布日期:

2021-09-05

简要介绍:

狼疮肾炎是系统性红斑狼疮引起的肾损害,主要表现为血尿、蛋白尿、水肿、高血压和肾功能不全等。现有的诱导治疗方案对增殖性狼疮肾炎的完全缓解率偏低,且狼疮肾炎容易复发。科学、规范地诊断和治疗狼疮肾炎十分重要。为此,中华医学会风湿病学分会在借鉴当前国内外经验和指南基础上,制定了本诊疗规范,旨在提高狼疮肾炎的疗效,减少复发,延缓肾损害的进展,改善患者预后。

下载附件:

(因为版权问题,不支持下载)

评论区 (26)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1215581, encodeId=f9bb12155814e, content=受益, beContent=null, objectType=guider, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e4bc2227682, createdName=米寻, createdTime=Fri Apr 29 13:08:57 CST 2022, time=2022-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1195878, encodeId=fad711958e83c, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/kA4fl6ACzmhJIAcD5pZc8KuBQu15eWYR5mdtb12bZ0cdA45wMItNgc6yzbg9oowa1ohn1L0gZ1TsLpH2NYiclGQ/132, createdBy=bbc12416289, createdName=ms6403861061114688, createdTime=Mon Feb 21 22:48:13 CST 2022, time=2022-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1189547, encodeId=1461118954e9d, content=good, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f88d5641277, createdName=ms5000001975231639, createdTime=Tue Feb 01 14:38:12 CST 2022, time=2022-02-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1188060, encodeId=99fd1188060c8, content=多一些详细诊疗指南, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f5ef6482787, createdName=ms5000001649854049, createdTime=Tue Jan 25 16:58:03 CST 2022, time=2022-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1179544, encodeId=10a411e954435, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6d165256693, createdName=147f2d23m71暂无昵称, createdTime=Sat Jan 01 16:12:09 CST 2022, time=2022-01-01, status=1, ipAttribution=)]
    2022-04-29 米寻

    受益

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1215581, encodeId=f9bb12155814e, content=受益, beContent=null, objectType=guider, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e4bc2227682, createdName=米寻, createdTime=Fri Apr 29 13:08:57 CST 2022, time=2022-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1195878, encodeId=fad711958e83c, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/kA4fl6ACzmhJIAcD5pZc8KuBQu15eWYR5mdtb12bZ0cdA45wMItNgc6yzbg9oowa1ohn1L0gZ1TsLpH2NYiclGQ/132, createdBy=bbc12416289, createdName=ms6403861061114688, createdTime=Mon Feb 21 22:48:13 CST 2022, time=2022-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1189547, encodeId=1461118954e9d, content=good, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f88d5641277, createdName=ms5000001975231639, createdTime=Tue Feb 01 14:38:12 CST 2022, time=2022-02-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1188060, encodeId=99fd1188060c8, content=多一些详细诊疗指南, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f5ef6482787, createdName=ms5000001649854049, createdTime=Tue Jan 25 16:58:03 CST 2022, time=2022-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1179544, encodeId=10a411e954435, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6d165256693, createdName=147f2d23m71暂无昵称, createdTime=Sat Jan 01 16:12:09 CST 2022, time=2022-01-01, status=1, ipAttribution=)]
    2022-02-21 ms6403861061114688

    学习了

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1215581, encodeId=f9bb12155814e, content=受益, beContent=null, objectType=guider, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e4bc2227682, createdName=米寻, createdTime=Fri Apr 29 13:08:57 CST 2022, time=2022-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1195878, encodeId=fad711958e83c, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/kA4fl6ACzmhJIAcD5pZc8KuBQu15eWYR5mdtb12bZ0cdA45wMItNgc6yzbg9oowa1ohn1L0gZ1TsLpH2NYiclGQ/132, createdBy=bbc12416289, createdName=ms6403861061114688, createdTime=Mon Feb 21 22:48:13 CST 2022, time=2022-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1189547, encodeId=1461118954e9d, content=good, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f88d5641277, createdName=ms5000001975231639, createdTime=Tue Feb 01 14:38:12 CST 2022, time=2022-02-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1188060, encodeId=99fd1188060c8, content=多一些详细诊疗指南, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f5ef6482787, createdName=ms5000001649854049, createdTime=Tue Jan 25 16:58:03 CST 2022, time=2022-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1179544, encodeId=10a411e954435, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6d165256693, createdName=147f2d23m71暂无昵称, createdTime=Sat Jan 01 16:12:09 CST 2022, time=2022-01-01, status=1, ipAttribution=)]
    2022-02-01 ms5000001975231639

    good

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1215581, encodeId=f9bb12155814e, content=受益, beContent=null, objectType=guider, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e4bc2227682, createdName=米寻, createdTime=Fri Apr 29 13:08:57 CST 2022, time=2022-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1195878, encodeId=fad711958e83c, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/kA4fl6ACzmhJIAcD5pZc8KuBQu15eWYR5mdtb12bZ0cdA45wMItNgc6yzbg9oowa1ohn1L0gZ1TsLpH2NYiclGQ/132, createdBy=bbc12416289, createdName=ms6403861061114688, createdTime=Mon Feb 21 22:48:13 CST 2022, time=2022-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1189547, encodeId=1461118954e9d, content=good, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f88d5641277, createdName=ms5000001975231639, createdTime=Tue Feb 01 14:38:12 CST 2022, time=2022-02-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1188060, encodeId=99fd1188060c8, content=多一些详细诊疗指南, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f5ef6482787, createdName=ms5000001649854049, createdTime=Tue Jan 25 16:58:03 CST 2022, time=2022-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1179544, encodeId=10a411e954435, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6d165256693, createdName=147f2d23m71暂无昵称, createdTime=Sat Jan 01 16:12:09 CST 2022, time=2022-01-01, status=1, ipAttribution=)]
    2022-01-25 ms5000001649854049

    多一些详细诊疗指南

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1215581, encodeId=f9bb12155814e, content=受益, beContent=null, objectType=guider, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e4bc2227682, createdName=米寻, createdTime=Fri Apr 29 13:08:57 CST 2022, time=2022-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1195878, encodeId=fad711958e83c, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/kA4fl6ACzmhJIAcD5pZc8KuBQu15eWYR5mdtb12bZ0cdA45wMItNgc6yzbg9oowa1ohn1L0gZ1TsLpH2NYiclGQ/132, createdBy=bbc12416289, createdName=ms6403861061114688, createdTime=Mon Feb 21 22:48:13 CST 2022, time=2022-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1189547, encodeId=1461118954e9d, content=good, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f88d5641277, createdName=ms5000001975231639, createdTime=Tue Feb 01 14:38:12 CST 2022, time=2022-02-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1188060, encodeId=99fd1188060c8, content=多一些详细诊疗指南, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f5ef6482787, createdName=ms5000001649854049, createdTime=Tue Jan 25 16:58:03 CST 2022, time=2022-01-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1179544, encodeId=10a411e954435, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6d165256693, createdName=147f2d23m71暂无昵称, createdTime=Sat Jan 01 16:12:09 CST 2022, time=2022-01-01, status=1, ipAttribution=)]
    2022-01-01 147f2d23m71暂无昵称

    很好

    0

拓展阅读

中国狼疮肾炎诊断和治疗指南

肾脏病相关专家小组(统称) · 2019-11-26

2019 EULAR/ERA-EDTA建议:狼疮肾炎的管理

欧洲抗风湿病联盟(EULAR,The European League Against Rheumatism) · 2020-03-27

正确解读国际狼疮肾炎临床实践指南

南方医科大学第三附属医院广东省骨科医院病理科 · 2014-03-01

狼疮肾炎治疗药物临床试验技术指导原则(公开征求意见稿)

国家药品监督管理局药品审评中心(CDE) · 2022-11-16